Peptide stack · Stack 03
Cellular & Mitochondrial Reference Stack
MOTS-C + NAD+ cellular-energy bench. A 2-peptide bundle for in vitro research workflows — supplied as reference materials at 10% off the sum of singles.
Bundle-priced
10% off the sum of singles — same rate as a Custom Stack.
One insured package
Single tracking number, one delivery — ships today on orders placed before cutoff.
For research use only. Not for human consumption. Not for veterinary use. All peptides supplied as reference materials for in vitro laboratory research by qualified researchers. Individual peptides in this stack may carry additional product-specific compliance notices — see each product page before checkout.
Your stack
What's in this stack.
For qualified researchers 18+. In vitro reference materials — see disclaimer.
- $59.00
MOTS-C
10mg
- $79.00
NAD+
500mg
You save $13.80
Why this stack.
MOTS-C with NAD+ — a mitochondrial reference pair commonly used together in cellular-energy and longevity-pathway research.
Every peptide ships as a reference material for in vitro laboratory research workflows — never sold for human or veterinary use, never sold as a diagnostic, therapeutic, or cosmetic preparation.
Every order. Verified.
≥99% HPLC purity floor — re-analysis typically runs higher. Damaged in transit? Not as described? Replaced or refunded within 48 hours.
For research use only
Every peptide in this stack is supplied strictly as a reference material for in vitro laboratory research. Not for human or veterinary use. Not for diagnostic, therapeutic, or cosmetic application. By checking out, every buyer acknowledges they are a qualified researcher 18+ acquiring these materials for legitimate research purposes only.
Read full quality + compliance docsStack questions.
- MOTS-C with NAD+ — a mitochondrial reference pair commonly used together in cellular-energy and longevity-pathway research. Each peptide is supplied as a reference material for in vitro laboratory research workflows — pairing them in a single shipment removes ordering friction for researchers running parallel protocols.